These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 17457900)

  • 1. Increased susceptibility of human respiratory syncytial virus to neutralization by anti-fusion protein antibodies on adaptation to replication in cell culture.
    Marsh R; Connor A; Gias E; Toms GL
    J Med Virol; 2007 Jun; 79(6):829-37. PubMed ID: 17457900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An investigation of the genetic basis of increased susceptibility to neutralization by anti-fusion glycoprotein antibody arising on passage of human respiratory syncytial virus in cell culture.
    Hiriote W; Gias EL; Welsh SH; Toms GL
    J Med Virol; 2015 Jan; 87(1):130-40. PubMed ID: 24861209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the binding of monoclonal and polyclonal antibodies to the glycoproteins of antigenic variants of human respiratory syncytial virus by surface plasmon resonance.
    McGill A; Marsh R; Craft AW; Toms GL
    J Immunol Methods; 2005 Feb; 297(1-2):143-52. PubMed ID: 15777938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of human respiratory syncytial virus A2 and 8/60 fusion glycoprotein gene sequences and mapping of sub-group specific antibody epitopes.
    Connor AL; Bevitt DJ; Toms GL
    J Med Virol; 2001 Feb; 63(2):168-77. PubMed ID: 11170054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of human respiratory syncytial virus genotype specific antibody responses in infants.
    McGill A; Greensill J; Marsh R; Craft AW; Toms GL
    J Med Virol; 2004 Nov; 74(3):492-8. PubMed ID: 15368511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of antibodies directed against human respiratory syncytial virus antigens present in two commercial preparations of human immunoglobulins with different neutralizing activities.
    Sastre P; Melero JA; García-Barreno B; Palomo C
    Vaccine; 2004 Dec; 23(4):435-43. PubMed ID: 15530691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selection and characterization of human respiratory syncytial virus escape mutants resistant to a polyclonal antiserum raised against the F protein.
    Tomé L; Frabasile S; Candia C; Pittini A; Farina N; Melero JA; Arbiza J
    Arch Virol; 2012 Jun; 157(6):1071-80. PubMed ID: 22411099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the antibody specificities of human convalescent-phase sera against the attachment (G) protein of human respiratory syncytial virus: influence of strain variation and carbohydrate side chains.
    Palomo C; Cane PA; Melero JA
    J Med Virol; 2000 Apr; 60(4):468-74. PubMed ID: 10686032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between the loss of neutralizing antibody binding and fusion activity of the F protein of human respiratory syncytial virus.
    Liu C; Day ND; Branigan PJ; Gutshall LL; Sarisky RT; Del Vecchio AM
    Virol J; 2007 Jul; 4():71. PubMed ID: 17623075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of complement in neutralization of respiratory syncytial virus.
    Yoder SM; Zhu Y; Ikizler MR; Wright PF
    J Med Virol; 2004 Apr; 72(4):688-94. PubMed ID: 14981775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal antibody-resistant mutants selected with a respiratory syncytial virus-neutralizing human antibody fab fragment (Fab 19) define a unique epitope on the fusion (F) glycoprotein.
    Crowe JE; Firestone CY; Crim R; Beeler JA; Coelingh KL; Barbas CF; Burton DR; Chanock RM; Murphy BR
    Virology; 1998 Dec; 252(2):373-5. PubMed ID: 9878616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age related differences in humoral immune response to respiratory syncytial virus infection in adults.
    Walsh EE; Falsey AR
    J Med Virol; 2004 Jun; 73(2):295-9. PubMed ID: 15122807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic stability of the attachment glycoprotein of human respiratory syncytial viruses during serial passages in cell cultures.
    de Sierra M; Arbiza J
    Acta Virol; 2004; 48(2):115-21. PubMed ID: 15462287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutralization susceptibility of African swine fever virus is dependent on the phospholipid composition of viral particles.
    Gómez-Puertas P; Oviedo JM; Rodríguez F; Coll J; Escribano JM
    Virology; 1997 Feb; 228(2):180-9. PubMed ID: 9123824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human monoclonal antibodies isolated from spontaneous Epstein-Barr virus-transformed tumors of Hu-SPL-SCID mice and specific for fusion protein display broad neutralizing activity toward respiratory syncytial virus.
    Chamat S; Walsh EE; Anderson D; Osta M; Awaraji C; Pan LZ; Ochi J; Shuey S; Brams P
    J Infect Dis; 1999 Aug; 180(2):268-77. PubMed ID: 10395839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Membrane-associated respiratory syncytial virus F protein expressed from a human rhinovirus type 14 vector is immunogenic.
    Dollenmaier G; Mosier SM; Scholle F; Sharma N; McKnight KL; Lemon SM
    Virology; 2001 Mar; 281(2):216-30. PubMed ID: 11277694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potent high-affinity antibodies for treatment and prophylaxis of respiratory syncytial virus derived from B cells of infected patients.
    Collarini EJ; Lee FE; Foord O; Park M; Sperinde G; Wu H; Harriman WD; Carroll SF; Ellsworth SL; Anderson LJ; Tripp RA; Walsh EE; Keyt BA; Kauvar LM
    J Immunol; 2009 Nov; 183(10):6338-45. PubMed ID: 19841167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conformational constraints of conserved neutralizing epitopes from a major antigenic area of human respiratory syncytial virus fusion glycoprotein.
    López JA; Andreu D; Carreño C; Whyte P; Taylor G; Melero JA
    J Gen Virol; 1993 Dec; 74 ( Pt 12)():2567-77. PubMed ID: 7506298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations of respiratory syncytial virus attachment glycoprotein G associated with resistance to neutralization by primate polyclonal antibodies.
    Sullender WM; Edwards KG
    Virology; 1999 Nov; 264(1):230-6. PubMed ID: 10544149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of two antigenic sites recognized by neutralizing monoclonal antibodies directed against the fusion glycoprotein of human respiratory syncytial virus.
    Arbiza J; Taylor G; López JA; Furze J; Wyld S; Whyte P; Stott EJ; Wertz G; Sullender W; Trudel M
    J Gen Virol; 1992 Sep; 73 ( Pt 9)():2225-34. PubMed ID: 1383404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.